Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study

بواسطة Choi, Peter, Farouk, Mourad, Manamley, Nick, Addison, Janet
منشور في 2013

Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study

بواسطة Donck, Jan, Gonzalez-Tabares, Lourdes, Chanliau, Jacques, Martin, Heike, Stamatelou, Kyriaki, Manamley, Nick, Farouk, Mourad, Addison, Janet
الحاوية / القاعدة Adv Ther (2014)

Data sharing and the evolving role of statisticians

بواسطة Manamley, Nick, Mallett, Steve, Sydes, Matthew R., Hollis, Sally, Scrimgeour, Alison, Burger, Hans Ulrich, Urban, Hans-Joerg
الحاوية / القاعدة BMC Med Res Methodol (2016)

Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study

بواسطة Schaefer, Franz, Hoppe, Bernd, Jungraithmayr, Therese, Klaus, Günter, Pape, Lars, Farouk, Mourad, Addison, Janet, Manamley, Nick, Vondrak, Karel
الحاوية / القاعدة Pediatr Nephrol (2015)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

بواسطة Zitt, Emanuel, Fouque, Denis, Jacobson, Stefan H., Malberti, Fabio, Ryba, Miroslav, Ureña, Pablo, Rix, Marianne, Dehmel, Bastian, Manamley, Nick, Vervloet, Marc
منشور في 2013

Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

بواسطة Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
الحاوية / القاعدة Nephrol Dial Transplant (2016)